Hodgkin | opacc

Dec 17, 2023

Nivolumab Associated With Higher Survival in Pediatric Advanced-Stage Hodgkin Lymphoma

Replacing brentuximab vedotin with nivolumab in first-line treatment combined with the chemotherapy regimen AVD improved progression-free...

Oct 31, 2023

Cranial Radiotherapy Predisposes Pediatric Cancer Survivors to Hypothyroidism

Hypothyroidism and hypogonadism are likely among cranial radiotherapy-treated survivors of childhood-onset acute lymphoblastic leukemia...

Jun 29, 2023

Research shows fertility challenges for women treated for childhood Hodgkin lymphoma

The research also found that women treated for Hodgkin lymphoma may have to try for longer to become pregnant; however, the majority of ...

Nov 4, 2022

Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse

Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination. Read...

Jul 26, 2022

Cardiovascular disease, not cancer, top cause of death among Hodgkin lymphoma survivors

Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated...

Dec 7, 2020

Long-Term Survivors of Childhood Hodgkin Lymphoma at Increased Risk for Neurocognitive Impairment

"Despite receiving no neurotoxic therapy directed to the central nervous system, long-term survivors of childhood Hodgkin lymphoma (HL)...

Dec 17, 2018

Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers

New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of...

Aug 29, 2016

Survivors of Hodgkin lymphoma face high cardiovascular toxicity burden

Cardiovascular toxicities occurred more frequently and severely among adult survivors of pediatric, adolescent and young adult Hodgkin...

Jul 27, 2016

Novel statistical method captures long-term health burden of pediatric cancer cures

Using a statistical method developed at St. Jude Children's Research Hospital, investigators found that survivors of pediatric Hodgkin...

Jun 14, 2016

Experimental drug offers hope for young cancer patients with Hodgkin's lymphoma

An experimental drug is offering new hope to young patients with Hodgkin lymphoma, an aggressive form of blood cancer. Read more here:...

1

Innovative surgery preserves limb growth for childhood bone cancer patients

CAR-T Cell Therapy Shows EFS Benefit in Pediatric Leukemia Subset

Global clinical trial shows improved survival rates for common childhood leukemia

More than half of children with cancer die in the hospital

A new CHOP research program is exploring ways to reduce long-term effects of cancer treatment

The ticking ‘epigenetic’ clock measures true biological age

Serum protein panel test can help identify cardiomyopathy risk in childhood cancer survivors

UCalgary researchers help preserve future fertility options for children impacted by cancer

How a Penn State professor developed a cancer-fighting drug for kids

New insights into risk assessment of rare, aggressive tumors in children